semaglutide legal team in dallas pancreatitis attorney What You Need to Know About the Ongoing Litigation and Your Rights Texas patients turn to clinics
Description
An investigational oral GLP-1 (orforglipron) is in late-stage development and may eventually offer an easier-to-take pill option, but it isnt yet approved
A causal relationship is far from established, but given the biological gradient (a necessary factor to determine causality), it should certainly prompt caution and further study
Post-marketing data have not revealed an increased incidence of MTC in patients treated with these medications, though the baseline incidence of this rare cancer type is very low (approximately 1-2 cases per 100,000 people annually)
YY: Writing review & editing, Funding acquisition, Supervision, Resources, Project administration, Formal analysis
